Cadence Capital Management’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-20,612
Closed -$1.59M 738
2018
Q2
$1.59M Buy
20,612
+226
+1% +$17K 0.09% 287
2018
Q1
$1.41M Sell
20,386
-4,322
-17% -$330K 0.09% 313
2017
Q4
$1.84M Buy
24,708
+236
+1% +$15.1K 0.12% 216
2017
Q3
$1.55M Buy
+24,472
New +$1.52M 0.1% 264
2014
Q3
Sell
-59,500
Closed -$4.13M 616
2014
Q2
$4.13M Sell
59,500
-20,880
-26% -$1.47M 0.2% 198
2014
Q1
$6.04M Sell
80,380
-46,950
-37% -$3.52M 0.25% 140
2013
Q4
$8.94M Sell
127,330
-25,100
-16% -$1.64M 0.34% 74
2013
Q3
$9.42M Sell
152,430
-42,180
-22% -$2.73M 0.32% 96
2013
Q2
$12M Buy
+194,610
New +$11.7M 0.56% 21

Other funds holding ESRX

Cadence Capital Management's ESRX Position: Q3 2018 in Review

Cadence Capital Management sold out of Express Scripts Holding Company (ESRX) in Q3 2018, closing a stake of 20,612 shares — an estimated $1.59M sold.

Cadence Capital Management first reported a position in ESRX in Q2 2013 and held it in 9 quarters. The position peaked at $12M in Q2 2013. 1,130 funds tracked by Wall St. Rank hold ESRX as of Q3 2018.

  • Cadence Capital Management reported no remaining Express Scripts Holding Company position as of Q3 2018 after selling out during the quarter.
  • Cadence Capital Management sold 20,612 Express Scripts Holding Company shares in Q3 2018, an estimated $1.59M.
  • Cadence Capital Management first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 9 quarters.
  • Cadence Capital Management's Express Scripts Holding Company position peaked at $12M in Q2 2013.
  • 1,130 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2018.

Based on Cadence Capital Management's 13F filing for Q3 2018, filed 2 Nov 2018.